BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Roswell Park Cancer Institute 

Elm and Carlton Streets

Buffalo  New York  14263  U.S.A.
Phone: 877-275-7724 Fax:


SEARCH JOBS










 Company News
Dr. Boris Kuvshinoff Named Chief Medical Quality Officer, Interim Chief Medical Officer At Roswell Park Cancer Institute 12/9/2014 11:27:54 AM
Roswell Park Cancer Institute Genomic Sequencing Test Wins New York State Approval 7/21/2014 12:58:10 PM
Fighting Cancer With Lasers And Nanoballoons That Pop, University of Waterloo, University at Albany, Roswell Park Cancer Institute, And McMaster University Study 4/3/2014 6:58:15 AM
Secondhand Smoke Tied To Miscarriages, Stillbirths, Roswell Park Cancer Institute Study 3/14/2014 6:07:57 AM
GenomOncology Collaborates With Roswell Park Cancer Institute On Informatics Solution For Next-Generation Sequencing 2/11/2014 9:33:24 AM
Chilly Temperatures Help Cancers Grow, Roswell Park Cancer Institute Study 11/19/2013 6:55:18 AM
Nektar Therapeutics (CA) (NKTR) and Roswell Park Cancer Institute Announce Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) as a Second-Line Treatment in Patients with Relapsed or Refractory Small Cell Lung Cancer (SCLC) 10/24/2013 11:25:48 AM
Zenalux Biomedical Research Partnership With Roswell Park Cancer Institute 8/20/2013 8:57:58 AM
Eli Lilly and Company (LLY), Roswell Park Cancer Institute Partner to Train Minority Clinical Trial Investigators 8/1/2013 9:50:32 AM
Cleveland Biolabs Inc. (CBLI), Incuron, and Roswell Park Cancer Institute Release: Cell Reports Publication Elucidates Role of FACT as Accelerator of Tumor Transformation and Potential Marker and Target of Aggressive Cancers 7/8/2013 9:58:18 AM
123